Imperial Innovations reveals total spend
Investments in ventures including Autifony Therapeutics have taken Imperial Innovations' outlay to £25.7 million for the past year.
News
Investments in ventures including Autifony Therapeutics have taken Imperial Innovations' outlay to £25.7 million for the past year.
News